Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O G Kolterman

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Clinical Therapeutics|March 1, 1992
Glyburide in non-insulin-dependent diabetes: an updateO G Kolterman
The Journal of Laboratory and Clinical Medicine|April 1, 1993
Type II diabetes: who has the keys?O G Kolterman
The American Journal of Medicine|September 20, 1985
Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitusO G Kolterman
Diabetes/Metabolism Reviews|April 1, 1987
The impact of sulfonylureas on hepatic glucose metabolism in type II diabeticsO G Kolterman
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1997
Amylin and glycaemic regulation: a possible role for the human amylin analogue pramlintideO G Kolterman
Clinics in Endocrinology and Metabolism|November 1, 1979
PancreasJ M Olefsky, O G Kolterman
The American Journal of Medicine|January 1, 1981
Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetesJ M Olefsky, O G Kolterman
Diabetes Care|May 1, 1984
The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetesO G Kolterman, J M Olefsky
Diabetes/Metabolism Reviews|September 1, 1988
Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport systemW T Garvey, O G Kolterman
The American Journal of Clinical Nutrition|April 1, 1984
The metabolic effects of 2-week fructose feeding in normal subjectsP A Crapo, O G Kolterman
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|March 1, 1992
Glyburide in non-insulin-dependent diabetes: an updateO G Kolterman
The Journal of Laboratory and Clinical Medicine|April 1, 1993
Type II diabetes: who has the keys?O G Kolterman
The American Journal of Medicine|September 20, 1985
Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitusO G Kolterman
Diabetes/Metabolism Reviews|April 1, 1987
The impact of sulfonylureas on hepatic glucose metabolism in type II diabeticsO G Kolterman
Diabetic Medicine : a Journal of the British Diabetic Association|June 1, 1997
Amylin and glycaemic regulation: a possible role for the human amylin analogue pramlintideO G Kolterman
Clinics in Endocrinology and Metabolism|November 1, 1979
PancreasJ M Olefsky, O G Kolterman
The American Journal of Medicine|January 1, 1981
Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetesJ M Olefsky, O G Kolterman
Diabetes Care|May 1, 1984
The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetesO G Kolterman, J M Olefsky
Diabetes/Metabolism Reviews|September 1, 1988
Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: role of the glucose transport systemW T Garvey, O G Kolterman
The American Journal of Clinical Nutrition|April 1, 1984
The metabolic effects of 2-week fructose feeding in normal subjectsP A Crapo, O G Kolterman
Pageof 8